This important study was conducted in Bangladesh, where at the time of the research tetanus accounted for 26 percent of all infant deaths.
Sixty-two tetanus patients aged 1 to 12 years and 55 patients aged 13 to 30 years received conventional antitetanus therapy. Additionally, 31 members of the younger group and 27 of the older group received injections of 1 gram of ascorbic acid [vitamin c] daily as a supplement to conventional therapy.
In the younger group receiving vitamin C, zero percent died, while 74 percent of those who did not get the injections failed to survive.
In the older group, 37 percent of those who got the vitamin C died, while 68 percent of those who did not get the vitamin C succumbed.
The effect of daily intravenous administration of 1,000 mg ascorbic acid (AA) in tetanus patients aged 1-30 years was studied. In the age group of 1-12 years, 31 patients were treated with AA as additional to antitetanus serum, sedatives and antibiotics.
Editor’s note: For those who insist on hard-nosed data before admitting the efficacy of injectable vitamin C, this study from Bangladesh should be an eye-opener. In 1937, Claus W. Jungeblut of Columbia University reported that vitamin C could neutralize tetanus toxin in guinea pigs. By 1954, Dr. Fred Klenner was using injectable vitamin C to treat tetanus in his medical practice. This research from Bangladesh validates Jungblut and Klenner’s finding in a rigorous medical trial using a control group.
It must be concluded that vitamin C, as far as its in vitro action is concerned, cannot be regarded as a specific detoxicant for any given virus or toxin, but rather as a substance which acts indiscriminately against a variety of toxins and viruses.
[T]he potential cost-benefit ratio of more research into and wider use of injectable vitamin C by mainstream medicine is too great to continue to ignore, especially in a world overflowing with medical need.
A total number of 117 tetanus patients addmitted into the Infectious Disease Hospital, Mohakhali, Dhaka were studied.